Skip to content

Marfan Syndrome Moderate Exercise Pilot

Evaluating the Effects of Moderate Physical Activity on Health and Well-being in Adolescents and Young Adults With Marfan Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04641325
Enrollment
23
Registered
2020-11-23
Start date
2020-11-09
Completion date
2022-12-20
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Marfan Syndrome

Keywords

Cardiovascular, Moderate Exercise, Physical Therapy

Brief summary

Marfan syndrome (MFS) affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities. The lack of exercise and deconditioning have detrimental effects including increasing weakness, joint pain, decreased endurance, and depressive symptoms. Given the significant paucity of data currently existing on the effects of exercise in humans with MFS, and the recent, optimistic findings in rodent models, this pilot trial was established to assess the effects of moderated dynamic exercise in adolescents and young adults with MFS.

Detailed description

Marfan syndrome (MFS) affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given anecdotal reports of aortic dissection, limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities, most commonly isometric exercise and contact sports. Published guidelines also suggest restriction from highly dynamic competitive sports. While clinicians may mean to restrict patients only from competitive sports, often children and families interpret this caution as applying to almost all exercise, resulting in a large number of patients with Marfan syndrome being sedentary. This lack of exercise and deconditioning likely have detrimental effects in increasing weakness and joint pain and decreasing endurance. Depressive symptoms are also not uncommon in Marfan syndrome, and may be triggered or exacerbated by guidance to acutely cease participation in sports at the time of diagnosis. To date, as far as the investigators are aware, there are no published controlled studies on the effects of dynamic exercise on human subjects. In 2017, Mas-Stachurska et al published a study suggesting that a moderate level of dynamic exercise mitigated progressive degradation of the cardiac structures typically seen in Marfan Syndrome in a rodent sample. This study suggests the possibility that the fears surrounding moderate exercise in humans may be unwarranted. In addition, this study suggests that moderate exercise may actually protect the aorta and myocardium, in addition to the numerous other physical and emotional benefits that have been shown to result from consistent exercise. The overall goal is to evaluate the effects of a moderate dynamic exercise program on measures of cardiovascular, muscular, and mental health in adolescents and young adults with Marfan syndrome. The investigators plan to perform a randomized pilot study to calculate effect estimates to perform a larger multi-center study. The objective is to 1) randomize 20 patients with Marfan syndrome age 12-21 years to current status (controls) versus a moderate dynamic exercise intervention, then 2) allow the control group patients to undergo the exercise intervention. The investigators will then compare outcomes between both the intervention and control groups, and between the baseline and post-intervention states. Specific outcome measures will include cardiovascular assessment: maximal oxygen uptake (max VO2), segmental and central aortic stiffness, ventricular mass and volume, and endothelial function, muscular/physical assessment: manual muscle testing (MMT), functional balance, and pain assessment, and quality of life/mental health assessment: health-related quality of life, depression and anxiety screening scales. The hypothesis is that the intervention of a moderate exercise program introduced by a licensed physical therapist will result in improvement in cardiovascular status, muscular health, and mental health without detrimental effects on the aortic wall.

Interventions

Patients will be educated on methods of self-evaluating exertion and cardiovascular effort by assessing respiratory rate and perceived exertion. Next, patients will be given options for cardiovascular activities and complete at a moderate level of activity for a minimum of 150 minutes per week. Patients will perform a combination of exercises under the supervision of a physical therapist until a mod intensity level is reached and sustained. Patients will be taught to use the activity tracker to record their heart rate, activity, and PES. Patients will have a phone call every week to assess status, answer questions, and provide guidance on progressing intensity or duration of exercise. At the end of 8 weeks all patients will return for re-assessment.

Sponsors

The Marfan Foundation
CollaboratorOTHER
Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

The primary investigator and the co-PI (physical therapist) will know whether testing is at baseline or follow-up, but will not know the cardiovascular outcome measures. The cardiovascular outcomes assessor will be fully blinded.

Intervention model description

The first part of trial was a Randomized Controlled Step-Wedge Pilot Trial as below 2 groups (Exercise Intervention Group and Current Care Group) The first phase of the study will maintain the Current Care Group as the control. At the end of the first phase, the Current Care Group will crossover and receive the Exercise Intervention as the second phase of the trial. With the COVID-19 pandemic causing delays in the study, and decreased enrollment and decreased access to MRI, the study was altered to a single group. comparing the same outcomes at baseline and after the intervention. This eliminates the blinding of the PI, but those interpreting the tests are still blinded.

Eligibility

Sex/Gender
ALL
Age
12 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Must be between the ages of 12-21 * Diagnosis of Marfan Syndrome * Must not have other conditions that limit the patients ability to perform exercise

Exclusion criteria

* Patients who have undergone aortic surgery * Patients with major congenital heart disease

Design outcomes

Primary

MeasureTime frameDescription
Maximum VO24 monthsMaximum VO2 in ml/kg/minute will be collected via Exercise Stress Test. Range 30-85, higher is better.

Secondary

MeasureTime frameDescription
Mean Diastolic blood pressure4 monthsmmHg, range 20-150, both low and high are abnormal, goal is age, sex and height-based, goal 10-50 percentile
Mean pulse pressure4 monthsmmHg, systolic blood pressure minus diastolic blood pressure, range 30-70 mmHg, goal is normal range for age and sex
Weight4 monthskg, range 50-300kg, lower is better, excluding underweight patients
BMI4 monthskg/m2, lower is better generally, excluding pts with BMI \<5% for age
Left ventricular strain by cardiac MRI4 monthsContinuous measure derived from post-processing MRI
Right ventricular strain by cardiac MRI4 monthsContinuous measure derived from post-processing MRI
Aortic root strain4 monthsContinuous measure %, higher is less stiff, Range 0-40
Aortic Root Distensibility4 months×10-3 mm Hg-1, Continuous measure, range 0.1-10
Aortic Root β-Stiffness index4 monthsNo units, Range 0.1-90
Maximum aortic root dimension4 monthsMeasured in cm, range 1-8cm
Aortic root z-score4 monthsNo units, based on body surface area published references, range -3 to 25
Aortic pulse wave velocity from MRI4 monthsmeters/second, range 0-30
Pulse wave velocity derived from applanation tonometry4 monthsmeters/second, range 0-30
Mean systolic blood pressure4 monthsmmHg, range 70-200, both low and high are abnormal, goal is age, sex and height-based, goal 10-50 percentile
Manual muscle testing score4 monthsGrade 0-5, higher is better
Reactive hyperemia index4 monthsno units, 0-4 range, higher is worse
Visual analog assessment of pain4 monthsno units, scale from 0-6, 6 is worse
Single Leg Stance Test4 monthsseconds, higher is better
Single limb squat test score4 monthsseconds, higher is better
Star Excursion Balance Test4 months%, range 0-100, higher is better
6M Timed Hop Test4 monthsmilliseconds, range 1 to infinity, lower is better
Scale for Child Anxiety Related Emotional Disorders (SCARED) (ages 12-18 y)4 months41 item scale, each with 3 point Likert scale, scale is summed, range 0-123, higher is worse
Quality of Life Scale (QOLS) (ages 19-21 y)4 months16 items, each with 7 point Likert, higher is worse
Pediatric Quality of Life Scale (PedsQL) scale scores4 monthsreported in 3 domains, each reported on Likert scale, scaled to 0-100 scale, lower is worse
Children's Depression Inventory (CDI) 2 (ages 12-18 y)4 months28-item assessment that yields a Total Score, 2 scale scores, and 4 subscale scores. For each item, respondent is presented with 3 choices that correspond to 3 levels of symptomatology: 0 (absence of symptoms), 1 (mild or probable symptom), or 2 (definite symptom). Lower is better
Depression, Anxiety, & Stress Scale (DASS) (ages 19-21 y)4 monthsset of 3 self-report scales. Each scale contains 14 items, each with a 4-point severity/frequency scale, higher is worse
Augmentation index4 months%, range 1-90

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026